Ligand profile
ROI
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2426 — 2-amino-4-hydroxy-6- hydroxymethyldihydropteridine diphosphokinase
Identifiers
Database identifiers and provenance.
- Ligand ID
ROI- PDB
1cbk- UniProt (similar protein)
P43777- Target protein
- VK055_2426
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.4
- −1 ≤ LogP ≤ 5 0.14
- MW ≤ 500 Da 209.2
- LogP ≤ 5 0.14
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 116.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1(C(=NC2=C(N1)N=C(NC2=O)N)O)CCC1(C(=NC2=C(N1)N=C(NC2=O)N)O)C
InChI=1S/C8H11N5O2/c1-8(2)6(15)10-3-4(13-8)11-7(9)12-5(3)14/h1-2H3,(H,10,15)(H4,9,11,12,13,14)InChI=1S/C8H11N5O2/c1-8(2)6(15)10-3-4(13-8)11-7(9)12-5(3)14/h1-2H3,(H,10,15)(H4,9,11,12,13,14)
JMLQSLXEUWNWFI-UHFFFAOYSA-NJMLQSLXEUWNWFI-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01288
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ROI →
- PDB RCSB structure 1cbk →
- UniProt UniProt P43777 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ROI”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2426.
PDB 27
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 21
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).